These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 25803498

  • 21. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Haas M, Mirocha J, Reinsmoen NL, Vo AA, Choi J, Kahwaji JM, Peng A, Villicana R, Jordan SC.
    Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
    [Abstract] [Full Text] [Related]

  • 22. The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection.
    Hardinger KL, Murillo D.
    Clin Transpl; 2011 Mar; ():401-8. PubMed ID: 22755438
    [Abstract] [Full Text] [Related]

  • 23. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection.
    Tower CM, Reyes M, Nelson K, Leca N, Kieran N, Muczynski K, Jefferson JA, Blosser C, Kukla A, Maurer D, Chandler W, Najafian B.
    Transplantation; 2017 Sep; 101(9):2235-2243. PubMed ID: 27846156
    [Abstract] [Full Text] [Related]

  • 24. The impact of C4d staining as a humoral injury marker.
    Kara M, Demir F, Ata P, Ozel L, Gumrukcu G, Unal E, Canbakan M, Gucun M, Esadoglu V, Ozdemir E, Cemel H, Titiz MI.
    Transplant Proc; 2012 Sep; 44(6):1694-6. PubMed ID: 22841245
    [Abstract] [Full Text] [Related]

  • 25. The prevalence of C4d-positive renal allografts in 134 consecutive biopsies in Thai patients.
    Cheunsuchon B, Vongwiwatana A, Premasathian N, Shayakul C, Parichatikanond P.
    Transplant Proc; 2009 Nov; 41(9):3697-700. PubMed ID: 19917370
    [Abstract] [Full Text] [Related]

  • 26. Cell mediated rejection revisited: Past, current, and future directions.
    Hara S.
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():45-51. PubMed ID: 29968416
    [Abstract] [Full Text] [Related]

  • 27. Clinicopathological analysis of transplant glomerulopathy cases.
    Shimizu T, Ishida H, Shirakawa H, Omoto K, Tsunoyama K, Iida S, Tanabe K, Yamaguchi Y.
    Clin Transplant; 2009 Aug; 23 Suppl 20():39-43. PubMed ID: 19594595
    [Abstract] [Full Text] [Related]

  • 28. C4d deposits in acute "cell-mediated" rejection: a marker for renal prognosis?
    Neves M, Cotovio P, Machado S, Santos L, Macário F, Alves R, Pratas J, Xavier da Cunha M, Mota A, Campos M.
    Transplant Proc; 2012 Oct; 44(8):2360-5. PubMed ID: 23026593
    [Abstract] [Full Text] [Related]

  • 29. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J, Xue W, Qing X, Jing X, Hou J, Tian X, Guo Q, He X, Cai J.
    Clin Transpl; 2014 Oct; ():223-30. PubMed ID: 26281149
    [Abstract] [Full Text] [Related]

  • 30. Failure of bortezomib to cure acute antibody-mediated rejection in a non-compliant renal transplant patient.
    Ryckewaert A, Allain-Launay E, Moreau A, Blancho G, Cesbron A, Blin N, Roussey G.
    Pediatr Transplant; 2013 Sep; 17(6):E131-6. PubMed ID: 23834525
    [Abstract] [Full Text] [Related]

  • 31. C4d-positive renal transplants: single-center clinical outcomes.
    Ciszek M, Ptasińska AP, Durlik M, Paczek L.
    Clin Transpl; 2006 Sep; ():405-12. PubMed ID: 18365397
    [Abstract] [Full Text] [Related]

  • 32. Clinicopathologic analysis of acute vascular rejection cases after renal transplantation.
    Shimizu T, Tanabe T, Omoto K, Ishida H, Tanabe K.
    Transplant Proc; 2012 Jan; 44(1):230-5. PubMed ID: 22310621
    [Abstract] [Full Text] [Related]

  • 33. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
    Ranjan P, Nada R, Jha V, Sakhuja V, Joshi K.
    Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
    [Abstract] [Full Text] [Related]

  • 34. Bortezomib as an adjuvant to conventional therapy in the treatment of antibody mediated rejection (AMR): the full spectrum.
    Al Meshari K, Pall A, Elgamal H, Alzayer F, Altalhi M.
    Clin Transpl; 2010 May; ():383-90. PubMed ID: 21696055
    [Abstract] [Full Text] [Related]

  • 35. Beyond Criteria and Definitions: Outcome of a Standardized Antibody-Mediated Rejection Protocol with a Diagnostic Schema Different from the Banff 2009 Criteria.
    Rendulic T, Ramon DS, Killen PD, Samaniego-Picota M, Park JM.
    Clin Transpl; 2014 May; ():179-87. PubMed ID: 26281143
    [Abstract] [Full Text] [Related]

  • 36. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
    Kikić Ž, Kainz A, Kozakowski N, Oberbauer R, Regele H, Bond G, Böhmig GA.
    Clin J Am Soc Nephrol; 2015 Aug 07; 10(8):1435-43. PubMed ID: 26071493
    [Abstract] [Full Text] [Related]

  • 37. Focal peritubular capillary C4d deposition in acute rejection.
    Magil AB, Tinckam KJ.
    Nephrol Dial Transplant; 2006 May 07; 21(5):1382-8. PubMed ID: 16396975
    [Abstract] [Full Text] [Related]

  • 38. The Pathophysiology and Impact of Inflammation in Nonscarred Renal Interstitium: The Banff i Lesion.
    Nankivell BJ, P'Ng CH, Shingde M, Viswanathan S, Achan A, Renthawa J, Sharma RN, Chapman JR.
    Transplantation; 2020 Apr 07; 104(4):835-846. PubMed ID: 31369519
    [Abstract] [Full Text] [Related]

  • 39. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA, Lehman AM, Nadasdy GM, Sedmak DD, Pesavento TE, Henry ML, Pelletier RP, Ferguson RM, Nadasdy T.
    Clin Transplant; 2008 Apr 07; 22(1):61-7. PubMed ID: 18217907
    [Abstract] [Full Text] [Related]

  • 40. Effective therapy for acute antibody-mediated rejection with mild chronic changes: case report and review of the literature.
    Gheith O, Al-Otaibi T, Nampoory N, Halim M, Nair P, Saied T, Al-Waheeb S, Muzeirei I, Ibraheim M.
    Exp Clin Transplant; 2012 Aug 07; 10(4):406-9. PubMed ID: 22746156
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.